http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113527390-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a34cb526265037dec025db86cb5336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f2b83fbb7a87ab529084c6ef6dd3e08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-795
filingDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8591c4923d193c2a2389322874fa811b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed3788f9fb23edf251b6bcd587174c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a277671b97ef8610b1a46f6b4f7d933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60bdadacb3318e70e5aa5bc22d7287bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12c80a8d2b3b2b07578163e50fa7ee71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5658cb8ef83dad4771eae7a0c0997ec3
publicationDate 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113527390-A
titleOfInvention Tulathromycin hapten, artificial antigen and antibody, and preparation method and application thereof
abstract The invention discloses a tulathromycin hapten, an artificial antigen and an antibody, a preparation method and application thereof, the tulathromycin hapten provided by the invention furthest reserves the characteristic structure of tulathromycin, and introduces maleimide group,the immunogenicity of the tulathromycin hapten is obviously enhanced; the tulathromycin artificial antigen obtained by coupling tulathromycin hapten and carrier protein is used for immunizing animals, so that the tulathromycin artificial antigen is more favorable for stimulating the immune response of the animals to generate antibodies with stronger specificity and higher sensitivity, and the IC of the tulathromycin antibodies to the tulathromycin is detected by an indirect competitive enzyme-linked immunosorbent assay 50 Is 0.3 mu g/L, has low cross reaction rate with other macrolide antibiotics, and provides a foundation for the subsequent establishment of various immunoassay methods of the tulathromycin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113603767-A
priorityDate 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451688096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426090796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456438065
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID715
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159677499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5480431
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID432487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407386600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9832301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426399464
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6V115
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID432487
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2RVI8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451005850
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01012
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578252

Total number of triples: 73.